Aiosyn, a notable medical software company with a focus on AI-based pathology solutions, has introduced Aiosyn Mitosis Research, a new addition to its Mitosis line. This innovative product features an advanced AI algorithm designed to automate the detection of cells undergoing division, known as mitoses, within whole slide images derived from cancer biopsies and resections. The primary aim of Aiosyn Mitosis Research is to facilitate research in pathology laboratories by streamlining the identification of mitotic figures.
"We are thrilled to introduce Aiosyn Mitosis Research, an AI-powered mitosis detection solution that will support cancer researchers with an innovative AI-based computational biomarker approach that improves the efficiency and consistency of results." commented Patrick de Boer, CEO of Aiosyn.
Image Credit: Aiosyn
What's Driving This Trend
- AI-powered Pathology Solutions
- The development of AI algorithms for pathology enables automation and improved efficiency in detecting abnormalities and biomarkers.
- Automated Mitosis Detection
- The introduction of AI-powered mitosis detection solutions streamlines the identification of cells undergoing division in cancer biopsies, enhancing research in pathology laboratories.
- AI in Cancer Research
- The use of AI algorithms in cancer research aids in the analysis of whole slide images, providing consistent and accurate results for further study.
Who This Affects Most
- Medical Software
- The medical software industry can leverage AI-powered pathology solutions to enhance disease diagnosis and treatment planning.
- Pathology Laboratories
- Pathology laboratories can integrate automated mitosis detection systems to improve research efficiency and ensure accurate identification of mitotic figures.
- Cancer Research
- The cancer research industry can benefit from AI algorithms that assist in automating the detection of mitotic figures, enabling faster analysis and more reliable results.
